NFIC has been proposed to act as a tumor suppressor in breast cancer, as it activates TP53, represses CCND1 and FOXF1, and is down-regulated by c-MYC and Ha-RAS oncogenes16–18,48,49. Here, MYC is linked to neoplasm.